FDA
-
-
-
-
-
-
-
60 Degrees Pharma gets safety board clearance for babesiosis trial
-
-
-
-
-
-
-
60 Degrees Pharma makes malaria drug available on telehealth platform
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
-
330,063 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

